Background Graft-versus-host disease (GVHD) is a common fatal complication of
hematopoietic stem cell transplantation (HSCT), where steroids are used as a treatment …

Hematopoietic allogeneic stem cell transplantation (allo-SCT) is a curative option for
patients with hematological malignancies. However, due to disparities in major and minor …

PURPOSE Chronic graft-versus-host disease (cGVHD) remains the major cause of late
morbidity after allogeneic hematopoietic cell transplantation. Colony-stimulating factor 1 …

Herein we review current practice regarding the management of chronic graft-vs.-host
disease (cGvHD) in paediatric patients after allogeneic haematopoietic stem cell …

Allogeneic haematopoietic stem cell transplantation (alloHSCT) offers a potentially curative
therapy for patients suffering from diseases of the haematopoietic system but requires a high …

The ruxolitinib compassionate use (CU) program offered ruxolitinib to patients≥ 2 years of
age with confirmed steroid-resistant acute or chronic graft-versus-host disease (aGvHD and …

Graft-versus-host disease (GvHD) of the skin is a severe allo-immune reaction and
complication following allogeneic stem cell transplantation. Over the past years, intensive …

Abstract Background & Objectives The primary objective of this observational study was to
perform an exhaustive description concerning patients receiving extracorporeal …

Background Infections are common with significant mortality and morbidity in patients with
graft‐versus‐host disease (GvHD). Extracorporeal photopheresis (ECP) is an advantageous …

Extracorporeal photopheresis (ECP) is considered a safe treatment modality. We aimed to
assess blood parameters including coagulation during ECP over time. We performed a long …